Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has appointed Glenn R. Larsen, Ph.D., as a new independent member of its Board of Directors. Dr. Larsen has extensive experience in the discovery, research and development of biologics, small molecule therapeutics and drug delivery medical devices for diverse clinical indications. Anika’s Board of Directors has voted to nominate Dr. Larsen for election by the stockholders at the 2015 Annual Meeting.
Help employers find you! Check out all the jobs and post your resume.
